Amarin Corp plc (ADR) (NASDAQ:AMRN)

CAPS Rating: 4 out of 5

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar nijinksi (< 20) Submitted: 1/27/2013 3:42:49 PM : Outperform Start Price: $8.40 AMRN Score: -116.63

no real competitors in this field

Featured Broker Partners


Advertisement